根治性膀胱切除术后移动术后症状干预工具与生物特征监测:评估可行性、可用性与潜在效用的初步研究
本研究为多阶段可行性与可用性研究,开发移动应用术后症状干预工具并经膀胱癌患者与照护者焦点小组评估。15例患者在膀胱切除术前前瞻性入组,出院后30天每日完成移动工具并佩戴生物特征监测设备。患者完成78%的每日调查,平均耗时152秒,所有患者认为每日调查易于使用;症状频率与严重程度在并发症或非计划医疗接触前或当时出现聚集。
要点
- 15例膀胱癌患者膀胱切除术后使用移动工具与可穿戴设备,30天内完成78%的每日调查。
- 平均完成术后症状干预工具时间为152秒,所有患者认为每日调查易于使用。
- 视觉模拟映射显示患者报告症状的频率与严重程度在并发症或非计划医疗接触前或当时聚集。
核心结论
- 使用智能手机与可穿戴技术捕获患者报告症状与生物特征数据在膀胱癌患者膀胱切除术后是可行的,且被评定为高度可用。
- 症状评分可能预示正在发生的并发症,并帮助临床医生识别可能从干预中获益的术后患者。
研究设计与样本
- 多阶段可行性与可用性研究,开发移动应用术后症状干预工具并由膀胱癌患者与照护者焦点小组评估。
- 患者在膀胱切除术前前瞻性入组,出院后30天每日完成移动术后症状干预工具并佩戴生物特征监测设备。
- 评估保留率、术后症状干预工具完成情况与可用性,并探索性分析每日症状与患者生成健康信息信号与术后并发症及再入院的相关性。
- 共15例患者,中位年龄72岁。
主要发现
- 15例患者在中位年龄72岁条件下,30天恢复期内完成78%的每日调查。
- 完成术后症状干预工具的平均时间为152秒。
- 所有患者同意每日调查易于使用,多数报告其比致电诊所更适合与照护团队沟通症状。
- 视觉模拟映射显示患者报告症状的频率与严重程度在并发症或非计划医疗接触前或当时出现聚集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Mobile health technology and integration of patient-reported outcome measures into clinical interventions have the potential to transform patient care. Though patient-reported outcome measure management has been shown to improve outcomes in ambulatory care settings, few studies have examined remote patient-reported outcome measure assessment after major cancer surgery. MATERIALS AND METHODS: A multiphased feasibility and usability study was designed. A mobile app-based postoperative symptom intervention tool was developed and evaluated by a focus group of bladder cancer patients and caregivers. Patients were prospectively accrued prior to cystectomy and asked to complete the daily mobile postoperative symptom intervention tool and wear biometric monitoring devices for 30 days post discharge. Retention, postoperative symptom intervention tool completion, and usability were assessed. Exploratory analysis of daily symptoms and patient-generated health information correlated signals with postsurgical complications and hospital readmission. RESULTS: Fifteen patients with a median age of 72 years completed 78% of daily surveys over the 30-day recovery period. Average time to complete the postoperative symptom intervention tool was 152 seconds. All patients agreed that the daily survey was easy to use, and most reported it would be a better way to communicate with the care team about symptoms than calling the clinic. Frequency and severity of patient-reported symptoms appeared to cluster prior to or at the time of complication or unplanned health care encounters on visual-analogue mapping. CONCLUSIONS: Using smartphone and wearable technology to capture patient-reported symptoms and biometric data is feasible and rated as highly usable by bladder cancer patients after cystectomy. Symptom scores may signal developing complications and help clinicians identify postsurgical patients who may benefit from intervention.
引用
- Huelster HL, Zemp L, Turner K, et al. Mobile Postoperative Symptom Intervention Tool and Biometric Monitoring After Radical Cystectomy: Pilot Study Evaluating Feasibility, Usability, and Potential Utility. J Urol. 2022. PMID: 36350586. doi:10.1097/JU.0000000000003048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。